logo

For the Inventor, By the Inventor

Takatsuki, Japan

Tomohiro Kawamoto

This inventor holds 8 USPTO granted patents. Top assignees: Takeda Chemical Industries, Inc., Takeda Pharmaceutical Company Limited, Shiseido Company, Limited. Active years: 1999-2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tomohiro Kawamoto. Retrieved from https://idiyas.com/inventor/tomohiro-kawamoto-rbtsyk8c

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 8

% Patents Active = 50.0

Average Co-Inventor Count = 4.2

ph-index = 2

Forward Citations = 16(Granted Patents)


Location History:

  • Ikeda, JP (1999 - 2001)
  • Ibaraki, JP (2004)
  • Takatsuki, JP (2007 - 2008)
  • Osaka, JP (2000 - 2013)

Company Filing History:

goldMedal4 out of 1,858 
 
Takeda Chemical Industries, Inc.
 patents
silverMedal3 out of 1,228 
 
Takeda Pharmaceutical Company Limited
 patents
bronzeMedal1 out of 1,040 
 
Shiseido Company, Limited
 patents
4. 1 out of 834,570 
Other
 patents
where one patent can have more than one assignee

Years Active: 1999-2013

Loading Chart...
8 patents (USPTO):Explore Patents
1. 8492378 - GSK-3β inhibitor (2013-07-23),
2. 7402595 - JNK inhibitor (2008-07-22),
3. 7199124 - JNK inhibitor (2007-04-03),
4. 6723522 - Sodium bicarbonate cotransporter protein (2004-04-20),
5. 6284500 - Microorganism resistant to threonine analogue and production of biotin (2001-09-04),
6. 6068990 - Proteins, their production and use (2000-05-30),
7. 6020173 - Microorganism resistant to threonine analogue and production of biotin (2000-02-01),
8. 5874277 - Proteins, their production and use (1999-02-23),

Title: The Innovations of Tomohiro Kawamoto

Introduction

Tomohiro Kawamoto is a notable inventor based in Takatsuki, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of inhibitors for various diseases. With a total of 8 patents to his name, Kawamoto's work has had a substantial impact on medical research and treatment options.

Latest Patents

Kawamoto's latest patents include a GSK-3β inhibitor, which aims to provide a compound useful for the prophylaxis or treatment of GSK-3β-related pathologies. This invention features an oxadiazole compound or its salts and prodrugs. Another significant patent is a JNK inhibitor, which contains a compound with an isoquinolinone skeleton. This compound is designed to target specific pathways in disease processes, showcasing Kawamoto's innovative approach to drug development.

Career Highlights

Throughout his career, Tomohiro Kawamoto has worked with prominent companies in the pharmaceutical industry, including Takeda Chemical Industries, Inc. and Takeda Pharmaceutical Company Limited. His experience in these organizations has allowed him to collaborate on various projects that advance medical science.

Collaborations

Kawamoto has worked alongside esteemed colleagues such as Hiroyuki Kimura and Yasushi Shintani. Their combined expertise has contributed to the successful development of innovative pharmaceutical solutions.

Conclusion

Tomohiro Kawamoto's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as a key innovator. His work continues to influence the development of treatments for complex diseases, making a lasting impact on healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…